Xiangxue Pharmaceutical Co., Ltd.

隶属于 guangzhou kunlun investment co. ltd.

The company was founded in 1997 and listed on the Shenzhen Stock Exchange GEM in 2010. The sole supplier of pharmaceuticals for the 2010 Guangzhou Asian Games, and the largest production base for medicinal oral liquids in the country. The company's main business is the manufacture of traditional Chinese medicines, integrating R&D, production and sales of modern traditional Chinese medicines and Chinese medicine tablets. The company's main products include antiviral oral solution, blue root granules, orange red series, reported varieties, metronidazofene buffen capsules, lidocaine aerosol, cephalexin capsules, Baiyun medical gel, Gaoxun medical catheters, drug distribution business, TAEST16001 and TAEST1901. Corporate honors: It was rated by “Forbes” as China's most promising growing enterprise, China's top 100 pharmaceutical company, the only pharmaceutical supplier at the 2010 Guangzhou Asian Games, the “Xiangxue” trademark was awarded as a well-known trademark in China, the largest pharmaceutical oral liquid production base in the country, the chairman unit of the Guangzhou Biotechnology Industry Alliance, “Guangzhou Academician Expert Workstation”, “2023 Guangdong Pharmaceutical Industry Science and Technology Innovation Advanced Unit”, “2023 Guangdong Pharmaceutical Industry Science and Technology Innovation Advanced Unit”, “2023 Chinese Herbal Medicine Brand Demonstration Base”, etc.